Open AccessCandidemia in COVID‐19 treated with corticosteroids and tocilizumab
Author(s) -
Yamamoto Koichiro,
Nakamura Kaoru,
Hagiya Hideharu,
Otsuka Fumio
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4858
Subject(s) - medicine , tocilizumab , covid-19 , intensive care medicine , immunology , virology , disease , outbreak , infectious disease (medical specialty) , rheumatoid arthritis
Abstract COVID‐19 patients treated with anti‐inflammatory drugs are rarely complicated by candidemia. Since immunosuppressive therapy can blunt inflammatory reactions, clinicians should actively survey latent candidemia during severe COVID‐19 treatment.